C. Levenback

932 total citations
16 papers, 699 citations indexed

About

C. Levenback is a scholar working on Surgery, Oncology and Obstetrics and Gynecology. According to data from OpenAlex, C. Levenback has authored 16 papers receiving a total of 699 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 6 papers in Oncology and 5 papers in Obstetrics and Gynecology. Recurrent topics in C. Levenback's work include Endometrial and Cervical Cancer Treatments (3 papers), Ovarian cancer diagnosis and treatment (2 papers) and Minimally Invasive Surgical Techniques (2 papers). C. Levenback is often cited by papers focused on Endometrial and Cervical Cancer Treatments (3 papers), Ovarian cancer diagnosis and treatment (2 papers) and Minimally Invasive Surgical Techniques (2 papers). C. Levenback collaborates with scholars based in United States. C. Levenback's co-authors include J. Taylor Wharton, Patricia J. Eifel, Thomas W. Burke, Judith K. Wolf, Diane C. Bodurka, Robert L. Coleman, David M. Gershenson, D. M. Gershenson, Mitchell Morris and Kevin R. Brader and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Gynecologic Oncology.

In The Last Decade

C. Levenback

15 papers receiving 674 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Levenback United States 11 383 348 187 184 126 16 699
J. Simm Canada 8 372 1.0× 281 0.8× 158 0.8× 112 0.6× 242 1.9× 11 623
Sait Okkan Türkiye 15 212 0.6× 183 0.5× 70 0.4× 189 1.0× 124 1.0× 39 654
Pearly Khaw Australia 11 319 0.8× 141 0.4× 129 0.7× 99 0.5× 169 1.3× 29 594
Hellmuth Pickel Austria 13 622 1.6× 349 1.0× 335 1.8× 156 0.8× 421 3.3× 39 906
Neil S. Horowitz United States 17 680 1.8× 161 0.5× 187 1.0× 103 0.6× 512 4.1× 29 854
Vitune Vongtama United States 14 307 0.8× 195 0.6× 130 0.7× 105 0.6× 159 1.3× 25 595
Jan C. Seski United States 17 745 1.9× 466 1.3× 374 2.0× 161 0.9× 392 3.1× 28 1.1k
H Pourquier France 12 602 1.6× 407 1.2× 248 1.3× 144 0.8× 183 1.5× 32 829
J.Taylor Wharton United States 15 417 1.1× 394 1.1× 241 1.3× 217 1.2× 399 3.2× 36 898
Robson Ferrigno Brazil 14 162 0.4× 289 0.8× 75 0.4× 222 1.2× 34 0.3× 46 653

Countries citing papers authored by C. Levenback

Since Specialization
Citations

This map shows the geographic impact of C. Levenback's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Levenback with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Levenback more than expected).

Fields of papers citing papers by C. Levenback

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Levenback. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Levenback. The network helps show where C. Levenback may publish in the future.

Co-authorship network of co-authors of C. Levenback

This figure shows the co-authorship network connecting the top 25 collaborators of C. Levenback. A scholar is included among the top collaborators of C. Levenback based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Levenback. C. Levenback is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Worley, Michael J., Ricardo dos Reis, Charlotte C. Sun, et al.. (2012). Impact of surgeon volume on patient safety in laparoscopic gynecologic surgery. Gynecologic Oncology. 125. S121–S121.
2.
Abu-Rustum, N.R., et al.. (2012). The utility of sentinel lymph node biopsy in the surgical management of women with vulvar melanoma. Gynecologic Oncology. 125. S84–S84. 1 indexed citations
3.
Schmeler, Kathleen M., Saroj Vadhan‐Raj, Pedro T. Ramírez, et al.. (2009). A phase II study of GM-CSF and rIFN-γ1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer. Gynecologic Oncology. 113(2). 210–215. 41 indexed citations
4.
Bast, Robert C., Revathy B. Iyer, Weixin Hu, et al.. (2008). A phase IIa study of a sequential regimen using azacitidine to reverse platinum resistance to carboplatin in patients with platinum resistant or refractory epithelial ovarian cancer. Journal of Clinical Oncology. 26(15_suppl). 3500–3500. 12 indexed citations
5.
Eifel, Patricia J., Anuja Jhingran, John V. Brown, C. Levenback, & Howard D. Thames. (2006). Time course and outcome of central recurrence after radiation therapy for carcinoma of the cervix. International Journal of Gynecological Cancer. 16(3). 1106–1111. 18 indexed citations
6.
Maluf, Fernando Cotait, Aliza Leiser, Paul Sabbatini, et al.. (2006). Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer. International Journal of Gynecological Cancer. 16(3). 1165–1171. 8 indexed citations
7.
Apte, Sachin M., Saroj Vadhan‐Raj, Lorenzo Cohen, et al.. (2005). Hemapoietic, immunomodulatory, antitumor, and toxicity profiles of sequential GM-CSF and IFNγ1b biotherapy and carboplatin in recurrent ovarian carcinoma. Journal of Clinical Oncology. 23(16_suppl). 5053–5053. 2 indexed citations
8.
Ramondetta, Lois M., et al.. (2004). Approaches for end-of-life care in the field of gynecologic oncology: an exploratory study. International Journal of Gynecological Cancer. 14(4). 580–588. 9 indexed citations
9.
Wolf, Judith K., et al.. (2004). Laparoscopic port-site metastases in patients with gynecological malignancies. International Journal of Gynecological Cancer. 14(6). 1070–1077. 10 indexed citations
10.
Levenback, C., Robert L. Coleman, Thomas W. Burke, et al.. (2001). Intraoperative Lymphatic Mapping and Sentinel Node Identification with Blue Dye in Patients with Vulvar Cancer. Gynecologic Oncology. 83(2). 276–281. 159 indexed citations
11.
Brader, Kevin R., et al.. (1998). Chemotherapy for cervical carcinoma: factors determining response and implications for clinical trial design.. Journal of Clinical Oncology. 16(5). 1879–1884. 58 indexed citations
12.
Levenback, C., Thomas W. Burke, Stephen C. Rubin, John P. Curtin, & J. Taylor Wharton. (1996). Arterial Occlusion Complicating Treatment of Gynecologic Cancer: A Case Series. Gynecologic Oncology. 63(1). 40–46. 11 indexed citations
13.
Miller, Brigitte, Mitchell Morris, David M. Gershenson, C. Levenback, & Thomas W. Burke. (1995). Intestinal Fistulae Formation Following Pelvic Exenteration: A Review of the University of Texas M. D. Anderson Cancer Center Experience, 1957-1990. Gynecologic Oncology. 56(2). 207–210. 33 indexed citations
14.
Gershenson, David M., Thomas W. Burke, C. Levenback, et al.. (1995). Combined Cisplatin and Carboplatin Chemotherapy for Treatment of Advanced Epithelial Ovarian Cancer. Gynecologic Oncology. 58(3). 349–355. 14 indexed citations
15.
Eifel, Patricia J., et al.. (1995). Time course and incidence of late complications in patients treated with radiation therapy for FIGO Stage IB carcinoma of the uterine cervix. International Journal of Radiation Oncology*Biology*Physics. 32(5). 1289–1300. 303 indexed citations
16.
Burke, Thomas W., et al.. (1994). Closure of complex vulvar defects using local rhomboid flaps.. PubMed. 84(6). 1043–7. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026